Genmab A GMAB
NASDAQ GMAB
$43.79 +3.79 (+9.48%)
At close: Oct 23, 2026 · 4:00 PM EDT

Genmab A (GMAB) Income Taxes Paid (2023 - 2026)

Updated

Analysis

Genmab A (GMAB) Income Taxes Paid (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes Paid (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn -
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn -
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 398.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 2.58 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn -
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 3.47 Bn
10 Genmab A 2.81 Bn -2.56 Bn 1.07 Bn 191.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 191.00 Mn
Mar 31, 2026 -95.00 Mn
Mar 31, 2025 -47.00 Mn
Dec 31, 2024 -50.00 Mn
Mar 31, 2024 -47.00 Mn
Dec 31, 2023 -155.00 Mn
Mar 31, 2023 -400.00 Mn
API Access

Genmab A Income Taxes Paid API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-taxes-paid&ticker=GMAB&period=max&api_key=YOUR_API_KEY